Skip to main content

Advertisement

Fig. 6 | BMC Infectious Diseases

Fig. 6

From: The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study

Fig. 6

Vacc-C5-induced T cell regulation. a Net regulation at week 1 (baseline), 6 (after initial immunisation), 15 (after1st boost) and 26 (after 2nd boost, end of study) in CD8+ (upper panel) and CD4+ (lower panel) T cell subsets. The change from baseline to end of study is indicated (Wilcoxon matched pairs test). b Net regulation as fold increase at week 1 and 26. The change from baseline to end of study is indicated (Wilcoxon matched pairs test)

Back to article page